Medical Condition News

RSS

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors.

13 Sep 2013

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Alzheimer's disease is thought to be caused by the buildup of abnormal, thread-like protein deposits in the brain, but little is known about the molecular structures of these so-called beta-amyloid fibrils.

13 Sep 2013

Using large doses of codeine may heighten sensitivity to pain

Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.

13 Sep 2013

Findings may help explain why some diabetic women prone to develop kidney failure

A genetic variant on chromosome 2 is strongly linked with kidney failure in diabetic women but not in men, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

13 Sep 2013

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

To prepare a potential new prostate cancer drug, called Gamitrinib, for trial in humans, The Wistar Institute has received a $1.5 million grant from the US Department of Defense's Congressionally Directed Medical Research Program.

13 Sep 2013

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."

13 Sep 2013

Brain atrophy leads to cognitive decline in T2DM people

New research has shown that cognitive decline in people with Type 2 Diabetes is likely due to brain atrophy, or shrinkage, that resembles patterns seen in the early stages of Alzheimer's disease.

13 Sep 2013

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis - the microbiological mechanisms have remained unclear.

13 Sep 2013

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

New research in mouse models suggests that treatment with antioxidants may help reduce behavioral issues linked to the genetic nervous system disorder Neurofibromatosis 1 (NF1) and an associated condition called Costello syndrome.

12 Sep 2013

Love Hormone May Play Role In Autism

...

12 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

New study to reduce unwanted side-effects of radiotherapy

Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.

From The University of Manchester 12 Sep 2013

Merlin and Hippo proteins interact to begin chain of events that control tissue growth

Johns Hopkins researchers have figured out the specific job of a protein long implicated in tumors of the nervous system. Reporting on a new study described in the Sept. 12 issue of the journal Cell, they detail what they call the "matchmaking" activities of a fruit fly protein called Merlin, whose human counterpart, NF2, is a tumor suppressor protein known to cause neurofibromatosis type II when mutated.

12 Sep 2013

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.

12 Sep 2013

New Tailored Activity Program to ease troublesome symptoms of dementia

A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.

12 Sep 2013

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

The American Society for Radiation Oncology (ASTRO) praises the "Delivering High-Quality Cancer Care: Charting a News Course for a System in Crisis" report, issued earlier today by the Institute of Medicine (IOM) of the National Academies.

12 Sep 2013

NIH budget slashing may stall future pain research funding

Multi-faceted pain research discoveries within the last decade are bringing new hope for the estimated 100 million Americans with chronic pain. Unfortunately, translation of these scientific advances into clinical practice could be stalled without sufficient funding for both basic science and clinical pain research, according to the American Pain Society.

12 Sep 2013

Current criteria for ALK positive lung cancer needs to be redefined

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

12 Sep 2013

Proper precautions may help people with allergies enjoy the beautiful fall weather

As summer comes to a close, kids head back to school and preparation for fall begins, don't' forget to consider fall allergies. An estimated 35 million Americans suffer from allergies, which in the fall begin in late August and peak in September. For those with fall allergies, three triggers typically occur - ragweed, indoor allergens and infections.

12 Sep 2013

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

If the unseasonable heat that is blanketing the Midwest doesn't affect area residents, the highest mold count for the 2013 allergy reporting season will. Gottlieb Allergy Count, the official allergy count for the Midwest, reports the mold count today is 85,000, a high for 2013, and well over the 50,000 threshold that signals a dangerous air quality warning.

12 Sep 2013

Medical Condition News

Nanodiamonds deliver chemotherapy directly into brain tumors

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Using large doses of codeine may heighten sensitivity to pain

Findings may help explain why some diabetic women prone to develop kidney failure

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Brain atrophy leads to cognitive decline in T2DM people

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

Love Hormone May Play Role In Autism

Omeros announces positive data from OMS824 Phase 1 clinical trial

New study to reduce unwanted side-effects of radiotherapy

Merlin and Hippo proteins interact to begin chain of events that control tissue growth

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

New Tailored Activity Program to ease troublesome symptoms of dementia

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

NIH budget slashing may stall future pain research funding

Current criteria for ALK positive lung cancer needs to be redefined

Proper precautions may help people with allergies enjoy the beautiful fall weather

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News